14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today DCPH ranks #15636 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Deciphera Pharmaceuticals Inc Stock Forecast NASDAQ:DCPH

$8.64 (4.10%)

Volume: 840k

Closed: Dec 08, 2021

Hollow Logo Score: -4.012

Deciphera Pharmaceuticals Inc Stock Forecast

$8.64 (4.10%)

Volume: 840k

Closed: Dec 08, 2021

Score Hollow Logo -4.012
Which way will DCPH go? Request
Key Stats
Beta 0.55
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 47 and the stock is currently not being overbought or oversold

Deciphera Pharmaceuticals Inc stock price up 4.1% on Wednesday
(Updated on Dec 08, 2021)

Sell candidate since 2021-11-05 Loss -2.04%

The Deciphera Pharmaceuticals Inc stock price gained 4.10% on the last trading day (Wednesday, 8th Dec 2021), rising from $8.30 to $8.64. , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 6.61% from a day low at $8.22 to a day high of $8.76. The price has risen in 6 of the last 10 days and is up by 3.97% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 7 thousand more shares were traded than the day before. In total, 840 thousand shares were bought and sold for approximately $7.25 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -56.87% during the next 3 months and, with a 90% probability hold a price between $1.76 and $10.66 at the end of this 3-month period.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, November 29, 2021, and so far it has risen 12.21%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Deciphera Pharmaceuticals Inc stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $17.58. On a fall, the stock will find some support from the short-term average at $8.26. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss

Deciphera Pharmaceuticals Inc finds support from accumulated volume at $8.63 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.54 between high and low, or 6.61%. For the last week, the stock has had a daily average volatility of 5.60%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Deciphera Pharmaceuticals Inc stock A Buy?

Deciphera Pharmaceuticals Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -4.012

Predicted Opening Price for Deciphera Pharmaceuticals Inc of Thursday, December 9, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 9, 2021 Current price
$8.54 $8.64 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Dec 01, 2021 "HC Wainwright" gave "$25.00 - $15.00" rating for DCPH. The price target was changed from $8.07 to 6.5%.

Volatility and Risk
Daily Average Volatility: 5.60 %
Overall Risk: Very High High Medium Low Very Low
5.60 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $8.82
Price: $8.64
Support: $8.63

DCPH Insider Trading Show all Trades



Last 100 transactions
Buy: 576 227 | Sell: 800 699 (Shares)
Date Action Amount Person Type
Oct 04, 2021 Sell 2 659 Sherman Matthew L Common Stock
Jun 23, 2021 Buy 12 000 Friedman Franklin Stuart Stock Option (Right to Buy)
Jun 23, 2021 Buy 12 000 Walsh Dennis Leo Stock Option (Right to Buy)
Jun 23, 2021 Buy 12 000 Allen Patricia L Stock Option (Right to Buy)
Jun 23, 2021 Buy 12 000 Kelley Susan L. Stock Option (Right to Buy)
Show all Insider Trades


Last 100 transactions
Buy: 576 227 | Sell: 800 699 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 9.08 5.11 %
8.87 2.71 %
8.75 1.23 %
Current price: 8.64
Support 8.33 -3.57 %
8.20 -5.05 %
8.00 -7.45 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 10.17 17.71 %
9.68 12.04 %
8.82 2.08 %
Current price 8.64
Support 8.63 -0.12%
8.35 -3.36%
7.70 -10.88%

Click to get the best stock tips daily for free!

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE